MoneyWorks4Me

Natco Pharma informs about board meeting

29 Oct 2018 Evaluate

Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018, to consider and approve approval of the Unaudited Financial Results for the quarter ended 30th September, 2018, and considreation of buy-back of equity shares of the Company and related matters.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..